Pfizer and CURE Consider the CT Bioscience Ecosystem
On March 9, a team of Pfizer executives visited The Commons. Theye were Angela Hwang, Global President, Pfizer Inflammation and Immunology; Mike Vincent, Chief Scientific Officer, Pfizer Inflammation and Immunology; Mike Corbo, Chief Development Officer, Pfizer Inflammation and Immunology; Nathan Etessami, Senior Director Business Operations, Pfizer Inflammation and Immunology; Sarah Kelly, Vice President, Pfizer Pharmaceutical Sciences and Barb Gierer, Site Affairs Lead, Groton Laboratories. Pfizer’s representative on the CURE Board of Director’s, John Burkhardt, Vice President, Global Drug Safety Research and Development and Groton Labs Site Director, also joined the conversation. Discussed were mechanisms for Pfizer scientists to further mentor local students interested in careers in bioscience, possible programming to educate the Connecticut bioscience community about drug discovery and development, and avenues of access to expertise for Connecticut start-ups. Also pictured: Susan Froshauer, President & CEO, CURE and Stan Choy, Co-Chair & Treasurer, CURE. Thank you, Pfizer, for the donation of “Building 286” to CURE so that Connecticut might have this commercial-grade lab space to foster its bioscience community.
CURE/CVG Investor & Entrepreneur Networking Event
Also on March 9, Crossroads Venture Group and CURE co-hosted an Investor and Entrepreneur Networking event. Ten Connecticut startups, including one of the Commons partners, Easymeeting, were showcased and given the opportunity to connect with investors and the many resources a company needs to launch, scale and fuel its growth. The evening also included 1:1 meetings with investors, pitches, and an opportunity for the startups to gain valuable feedback from the investment and entrepreneurial community.
Bioscience ClubhouseCT Presents – Students and Science: High School Science Fair Mentoring
On February 23rd thirty-five high school students from Norwich Tech’s Bioscience and Health Tech programs received top-shelf feedback on their draft State Science Fair presentations from a team of Pfizer scientists. Read full article here.
Bioscience ClubhouseCT presents: Preserving Sight – Leading the Fight to Eradicate Blindness
At another Bioscience ClubhouseCT event on February 16, Nicole Wagner, PhD, CEO of LambdaVision, and Mark Roser,Founder of KeepSight, made back-to-back presentations on their respective research and development in the area of retinal research. Their areas of research are distinctly different. Whereas KeepSight is focused on tools for home monitoring and health decision to help those with macular and retinal disease, Nicole Wagner leads her UConn company in the development of a protein-based retinal implant to restore vision to patients suffering from AMD and RP.